Cargando…

Protective anti-tumor vaccination against glioblastoma expressing the MHC class II transactivator CIITA

Glioblastoma is the most malignant tumor of the central nervous system. Current treatments based on surgery, chemotherapy, and radiotherapy, and more recently on selected immunological approaches, unfortunately produce dismal outcomes, and less than 2% of patients survive after 5 years. Thus, there...

Descripción completa

Detalles Bibliográficos
Autores principales:	Celesti, Fabrizio, Gatta, Andrea, Shallak, Mariam, Chiaravalli, Anna Maria, Cerati, Michele, Sessa, Fausto, Accolla, Roberto S., Forlani, Greta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040613/ https://www.ncbi.nlm.nih.gov/pubmed/36993983 http://dx.doi.org/10.3389/fimmu.2023.1133177

Ejemplares similares

Unveiling the Hidden Treasury: CIITA-Driven MHC Class II Expression in Tumor Cells to Dig up the Relevant Repertoire of Tumor Antigens for Optimal Stimulation of Tumor Specific CD4+ T Helper Cells
por: Forlani, Greta, et al.
Publicado: (2020)

The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1
por: Forlani, Greta, et al.
Publicado: (2015)

The MHC Class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation
por: Abdallah, Rawan, et al.
Publicado: (2014)

MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to, and affecting Tax-2 intracellular localization
por: Orlandi, Chiara, et al.
Publicado: (2011)

The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells
por: Forlani, Greta, et al.
Publicado: (2016)

The NLR member CIITA: Master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy
por: Forlani, Greta, et al.
Publicado: (2023)

The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators
por: Forlani, Greta, et al.
Publicado: (2013)

The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T-Cell Lymphotropic Virus Type 1
por: Tosi, Giovanna, et al.
Publicado: (2011)

Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1
por: Forlani, Greta, et al.
Publicado: (2019)

CIITA-Driven MHC Class II Expressing Tumor Cells as Antigen Presenting Cell Performers: Toward the Construction of an Optimal Anti-tumor Vaccine
por: Accolla, Roberto S., et al.
Publicado: (2019)

Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication
por: Orlandi, Chiara, et al.
Publicado: (2011)

Degradation, Promoter Recruitment and Transactivation Mediated by the Extreme N-Terminus of MHC Class II Transactivator CIITA Isoform III
por: Beaulieu, Yves B., et al.
Publicado: (2016)

Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses
por: Forlani, Greta, et al.
Publicado: (2017)

MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses
por: Bruchez, Anna, et al.
Publicado: (2020)

The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins
por: León Machado, Jorge Alfonso, et al.
Publicado: (2021)

Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes
por: Bissa, Massimiliano, et al.
Publicado: (2018)

Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes
Publicado: (1994)

CIITA-Transduced Glioblastoma Cells Uncover a Rich Repertoire of Clinically Relevant Tumor-Associated HLA-II Antigens
por: Forlani, Greta, et al.
Publicado: (2021)

HTLV-1 Infection and Pathogenesis: New Insights from Cellular and Animal Models
por: Forlani, Greta, et al.
Publicado: (2021)

Maturation of Dendritic Cells Is Accompanied by Rapid Transcriptional Silencing of Class II Transactivator (Ciita) Expression
por: Landmann, Salomé, et al.
Publicado: (2001)

Class II Transactivator (CIITA) Enhances Cytoplasmic Processing of HIV-1 Pr55Gag
por: Porter, Kristen A., et al.
Publicado: (2010)

Interaction Analysis between HLA-DRB1 Shared Epitope Alleles and MHC Class II Transactivator CIITA Gene with Regard to Risk of Rheumatoid Arthritis
por: Ronninger, Marcus, et al.
Publicado: (2012)

Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1
por: Forlani, Greta, et al.
Publicado: (2017)

Genomic mapping of the MHC transactivator CIITA using an integrated ChIP-seq and genetical genomics approach
por: Wong, Daniel, et al.
Publicado: (2014)

SIRT1 links CIITA deacetylation to MHC II activation
por: Wu, Xiaoyan, et al.
Publicado: (2011)

Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA
Publicado: (1994)

Dysregulated Recruitment of the Histone Methyltransferase EZH2 to the Class II Transactivator (CIITA) Promoter IV in Breast Cancer Cells
por: Truax, Agnieszka D., et al.
Publicado: (2012)

Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia
por: Forlani, Greta, et al.
Publicado: (2021)

Role of PU.1 in MHC Class II Expression via CIITA Transcription in Plasmacytoid Dendritic Cells
por: Miura, Ryosuke, et al.
Publicado: (2016)

PML promotes MHC class II gene expression by stabilizing the class II transactivator
por: Ulbricht, Tobias, et al.
Publicado: (2012)

Class II transactivator (CIITA) mediates transcriptional repression of pdk4 gene by interacting with hypermethylated in cancer 1 (HIC1)
por: Fang, Mingming, et al.
Publicado: (2015)

Boosting the MHC Class II-Restricted Tumor Antigen Presentation to CD4+ T Helper Cells: A Critical Issue for Triggering Protective Immunity and Re-Orienting the Tumor Microenvironment Toward an Anti-Tumor State
por: Accolla, Roberto S., et al.
Publicado: (2014)

Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours
por: Ong, Chrissie E. B., et al.
Publicado: (2022)

CIITA promoter I CARD-deficient mice express functional MHC class II genes in myeloid and lymphoid compartments
por: Zinzow-Kramer, Wendy M., et al.
Publicado: (2012)

CIITA and Its Dual Roles in MHC Gene Transcription
por: Devaiah, Ballachanda N., et al.
Publicado: (2013)

The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing
por: Shallak, Mariam, et al.
Publicado: (2022)

FBXO11 constitutes a major negative regulator of MHC class II through ubiquitin-dependent proteasomal degradation of CIITA
por: Kasuga, Yusuke, et al.
Publicado: (2023)

An Isotype-specific Activator of Major Histocompatibility Complex (MHC) Class II Genes That Is Independent of Class II Transactivator
por: Douhan, John, et al.
Publicado: (1997)

A dual defensive role of CIITA against retroviral infections
por: Tosi, Giovanna, et al.
Publicado: (2006)

The class II transactivator (CIITA) is regulated by post-translational modification cross-talk between ERK1/2 phosphorylation, mono-ubiquitination and Lys(63) ubiquitination
por: Morgan, Julie E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_niftc4hkv9cj6mdo6kve7235sh